Home › Funds › QVT Financial LP › BHVN
QVT Financial LP position in BHVN
BIOHAVEN LTD · Health Care
QVT Financial LP reported holding 354,206 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$5.3M, representing 0.31% of its reported portfolio and ranking #31 among its reported holdings. QVT Financial LP has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How QVT Financial LP's BHVN position evolved
QVT Financial LP first disclosed a stake in BHVN in Q3 2023 at 214,409 shares (US$5.6M). The position peaked in Q1 2024 at 170,006 shares, worth US$9.3M. Across 12 filings, QVT Financial LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 354,206 shares valued at US$5.3M — an increase of 184,200 shares quarter over quarter.. Notable position changes include a 108% increase in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 214.41K | $5.58M | New |
| Q4 2023 | 214.41K | $9.18M | Hold |
| Q1 2024 | 170.01K | $9.30M | Reduce |
| Q2 2024 | 170.01K | $5.90M | Hold |
| Q3 2024 | 170.01K | $8.50M | Hold |
| Q4 2024 | 170.01K | $6.35M | Hold |
| Q1 2025 | 170.01K | $4.09M | Hold |
| Q2 2025 | 170.01K | $2.40M | Hold |
| Q3 2025 | 170.01K | $2.55M | Hold |
| Q4 2025 | 170.01K | $1.92M | Hold |
| Q1 2026 | 170.01K | $1.44M | Hold |
| Q2 2026 | 354.21K | $5.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on QVT Financial LP
FAQ
How long has QVT Financial LP held BHVN?
QVT Financial LP has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is QVT Financial LP's current position in BHVN?
As of Q2 2026, QVT Financial LP holds 354.21K shares of BHVN (BIOHAVEN LTD), valued at $5.27M, representing 0.31% of its reported portfolio and ranking #31.
Has QVT Financial LP been buying or selling BHVN?
In the latest 13F filing (Q2 2026), QVT Financial LP increased its position in BHVN. The position peaked in Q1 2024 at 170.01K shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.